2024年5月27日，歐盟食品安全局（EFSA）發(fā)布消息，歐盟食品安全局（EFSA）發(fā)布關(guān)于植物乳桿菌（Lactiplantibacillus plantarum）DSM 18112作為所有動物飼料添加劑的授權(quán)更新申請的評估。
經(jīng)過評估，專家小組得出結(jié)論，該添加劑在授權(quán)使用條件下對所有動物物種、消費(fèi)者和環(huán)境都是安全的。在授權(quán)更新的情況下，無需評估添加劑的功效。部分原文報(bào)道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of Lactiplantibacillus plantarum (formerly Lactobacillus plantarum) DSM 18112 as a technological additive (functional group: silage additive) for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive remains safe for all animal species, consumers and the environment. Regarding user safety, the Panel concluded that owing to the nature of the additive, Lactiplantibacillus plantarum DSM 18112 should be considered a potential skin and respiratory sensitiser, and that any exposure through the skin and respiratory tract is considered a risk. The Panel could not conclude on the eye irritation potential of the additive due to the lack of data. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
經(jīng)過評估，專家小組得出結(jié)論，該添加劑在授權(quán)使用條件下對所有動物物種、消費(fèi)者和環(huán)境都是安全的。在授權(quán)更新的情況下，無需評估添加劑的功效。部分原文報(bào)道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of Lactiplantibacillus plantarum (formerly Lactobacillus plantarum) DSM 18112 as a technological additive (functional group: silage additive) for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive remains safe for all animal species, consumers and the environment. Regarding user safety, the Panel concluded that owing to the nature of the additive, Lactiplantibacillus plantarum DSM 18112 should be considered a potential skin and respiratory sensitiser, and that any exposure through the skin and respiratory tract is considered a risk. The Panel could not conclude on the eye irritation potential of the additive due to the lack of data. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
